Document is current
Any future updates will be listed below
-
Authors
Chu, Victoria T. https://orcid.org/0000-0002-7480-965X
Glascock, Abigail
Donnell, Deborah
Grabow, Cole
Brown, Clare E. https://orcid.org/0000-0003-3963-1339
Ward, Ryan
Love, Christina
Kalantar, Katrina L.
Cohen, Stephanie E. https://orcid.org/0000-0002-1632-1074
Cannon, Chase https://orcid.org/0000-0002-2962-754X
Woodworth, Michael H. https://orcid.org/0000-0002-6181-4599
Kelley, Colleen F.
Celum, Connie
Luetkemeyer, Anne F. https://orcid.org/0000-0003-0911-1578
Langelier, Charles R. https://orcid.org/0000-0002-6708-4646
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Chan Zuckerberg Biohub
Chan Zuckerberg Initiative
- License Information
-
More Information
Article History
Received: 9 April 2024
Accepted: 28 August 2024
First Online: 3 October 2024
Competing interests
: Mayne Pharmaceuticals donated doxycycline hyclate to the study, and Cepheid and Hologic provided reagents and STI diagnostic assays. Several authors have served as scientific advisors: to Merck (C. Celum and D.D.), to Gilead Sciences (C. Celum), to GlaxoSmithKline (C. Celum) and to Vir Biotechnology (A.L.). The other authors have no conflict of interests to declare.
